SMITH SCOTT THOMAS bought ASND
May 29, 2026 · Form 4 insider transaction
SMITH SCOTT THOMAS bought 250 shares of Ascendis Pharma A/S at $223.32 per share, a transaction worth $55.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
250
Price
$223.32
Total value
$55.8K
InsiderSMITH SCOTT THOMAS
RoleOfficer
CompanyAscendis Pharma A/S (ASND)
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateMay 29, 2026
Filing dateJune 1, 2026
Shares owned after4,267
OwnershipDirect
10b5-1 planNo
AmendedNo